SCANPHARM A/S: Financial statements 2018
CVR: 16279099
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 19,563,917 and a net result of DKK -2,876,360 compared with DKK -228,236 the year before. That is an increase of 2.6% compared with the year before. Equity in the 2018 report amounted to DKK 9,867,009. The solvency ratio was 25.8%. The company had 46 employees in the financial year.
- Gross Profit
- DKK 19,563,917
- Profit/Loss
- DKK -2,876,360
- Equity
- DKK 9,867,009
- Total Assets
- DKK 38,186,386
- Employees
- 46
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 19.6 mio. | -2.9 mio. | 9.9 mio. | 46 |
| 2017 | - | 19.1 mio. | -228 t. | 12.7 mio. | 43 |
| 2016 | - | 19.6 mio. | 1.3 mio. | 13 mio. | 42 |
| 2015 | - | 20.4 mio. | 716 t. | 11.7 mio. | 42 |
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
SCANPHARM A/S has published its annual report for 2017. Gross profit came to DKK 19,072,265, and the net result was DKK -228,236.
As of January 30, 2018, Rolf Eckersberg is registered as director of SCANPHARM A/S.
As of January 30, 2018, Ole Bjørn Jensen has stepped down as director of SCANPHARM A/S.
As of January 22, 2018, Peluli Holding ApS is registered as an owner of SCANPHARM A/S with an ownership share of 10%.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.